Cardiac resynchronization therapy (CRT) can have a profound therapeutic impact on appropriately selected patients. However, even when the current clinical guidelines for CRT1 are rigorously applied, the response rate is ≈70%. Nearly a third of patients who undergo implantation of a CRT device are clinical nonresponders and more may be "remodeling nonresponders.
展开▼
机译：Cardiac resynchronization therapy (CRT) can have a profound therapeutic impact on appropriately selected patients. 然而，即使当施加严格的CRT1的当前临床指南时，响应速率也≈70％。 几乎三分之一的接近CRT装置的患者是临床无反应者，并且更高可能是“重塑无关。
展开▼
